Allogeneic transfusion risks in the surgical patient

Harvey G. Klein

Research output: Contribution to journalArticlepeer-review

Abstract

The risk of blood transfusion-associated complications has been reduced in the past 10 years through technical advances in testing of blood, viral inactivation of noncellular blood components, enforcement of stringent donor selection criteria, and the use of alternatives to allogeneic transfusion. Even so, a zero-risk blood supply is unfeasible. The general public perceives infectious complications to be the most significant risk: although the greatest fear is associated with transmission of human immunodeficiency virus (HIV), at least three hepatitis viruses are transmissible by all blood components. Human immunodeficiency virus accounts for

Original languageEnglish (US)
JournalAmerican Journal of Surgery
Volume170
Issue number6 suppl. 1
StatePublished - 1995
Externally publishedYes

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Allogeneic transfusion risks in the surgical patient'. Together they form a unique fingerprint.

Cite this